Sana Biotechnology Inc vs Snowflake Inc — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while Snowflake Inc trades at $271.42 (market cap $95.09B). The key difference: Snowflake Inc is far larger — about 108.8× Sana Biotechnology Inc's market cap, and Snowflake Inc is trading nearer its 52-week high, Sana Biotechnology Inc nearer its low. Which is the better fit depends on your goals.
| SANA | SNOW | |
|---|---|---|
Market Cap | $873.84M | $95.09B |
Sector | Health | Technology |
52-Week High | $5.92 | $280.16 |
52-Week Low | $2.68 | $121.11 |
Enterprise Value | $848.03M | $94.90B |
Trailing returns across standard periods
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →Founded in 2012, Snowflake is a data lake, warehousing, and sharing company that came public in 2020. To date, the company has over 3,000 customers including nearly 30% of the Fortune 500 as its customers. Snowflake's data lake stores unstructured and semistructured data that can then be used in analytics to create insights stored in its data warehouse. Snowflake's data sharing capability allows enterprises to easily buy and ingest data almost instantaneously compared with a traditionally months-long process. Overall, the company is known for the fact that all of its data solutions that can be hosted on various public clouds.
Read more on SNOW →